Evidence map›Paper›PMID 35246696›Full record

ArticleAdvances in biochemical engineering/biotechnology2022

Achieving Commercial Applications for Microbial Biosurfactants.

Roger Marchant, Ibrahim M Banat

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in biochemical engineering/biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Roger MarchantSchool of Biomedical Sciences, University of Ulster, Coleraine, UK.
Ibrahim M BanatSchool of Biomedical Sciences, University of Ulster, Coleraine, UK. im.banat@ulster.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are numerous biosurfactant producing strains and products reported annually most of which aspiring to potential future industrial and environmental applications. Only a few of these compounds have reached commercial applications due to many impediments to large-scale production and applications. We investigate some of the important criteria and investigations required to achieve such future commercial application.

Indexed as

Surface-Active AgentsSurface-Active AgentsCommercial exploitationDownstream processingMicrobial biosurfactantsProduction costSafety

Identifiers

PMID35246696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.